DePuy Synthes, a provider orthopedic technologies and part of Johnson & Johnson, today announced it has acquired Expanding Innovations (EI), an emerging company specializing in expandable implant technology for spine surgery.
EI is a commercial-stage medical technology company focused on developing and commercializing expandable implant technologies for spine surgery. Its proprietary, non-screw-based interbody cage technology is designed to help mitigate the incidence of post-operative cage collapse and vertebral body subsidence, while supporting procedural efficiency and implant stability.
EI’s commercial portfolio includes the X-PAC TLIF Expandable Posterior Cage, X-PAC LLIF Expandable Lateral Cage System, and X-PAC N-GAGE Lumbar Plate System. Building on strong surgeon adoption and clinical experience, EI continues to advance its innovation pipeline with the planned expansion of the X-PAC portfolio, including next-generation Transforaminal Lumbar Interbody Fusion (TLIF) and Lateral lumbar Interbody Fusion (LLIF) cages, enhanced instrumentation, and future expansion into Anterior Lumbar Interbody Fusion (ALIF).
Expanding Innovations’ technology will complement the DePuy Synthes TriALTIS Spine System and be integrated into the VELYS Enabling Tech portfolio for Spine, creating a more comprehensive offering for both surgeons and patients.
“Expanding Innovations is an exciting addition to DePuy Synthes and furthers our commitment to bringing market-leading solutions across our Spine portfolio,” said Namal Nawana, worldwide president at DePuy Synthes, in a statement. “Our current portfolio and EI's innovation pipeline will strengthen our position in this high growth segment while expanding our ability to deliver meaningful innovation for surgeons and patients.”
